Monoamine Transporters Genotypes: Risk of PTSD and Related Comorbidities

PHASE3CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
PTSD
Interventions
DRUG

Paroxetine

SSRI

Trial Locations (1)

29401-5799

Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT00403455 - Monoamine Transporters Genotypes: Risk of PTSD and Related Comorbidities | Biotech Hunter | Biotech Hunter